ChemicalBook >> CAS DataBase List >>Acebutolol

Acebutolol

CAS No.
37517-30-9
Chemical Name:
Acebutolol
Synonyms
Prent;Sectral;ACEBUTOLOL;Acebutololum;Acetobutolol;dl-Acebutolol;Acebutolo HCl;Acebutolol USP/EP/BP;AcebutololDiscontinued. See: A123800;3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide
CBNumber:
CB5393651
Molecular Formula:
C18H28N2O4
Molecular Weight:
336.43
MDL Number:
MFCD00599435
MOL File:
37517-30-9.mol
Last updated:2023-06-08 09:03:05

Acebutolol Properties

Melting point 119-123°C
Boiling point 472.9°C (rough estimate)
Density 1.1748 (rough estimate)
refractive index 1.5700 (estimate)
storage temp. -20°C Freezer
solubility DMF: 10 mg/mL,DMSO: 5 mg/mL,Ethanol: 5 mg/mL,PBS (pH 7.2): 0.3 mg/mL
form A solid
pka pKa 9.40 (Uncertain)
color Crystals
Water Solubility 259 mg/L
CAS DataBase Reference 37517-30-9(CAS DataBase Reference)
FDA UNII 67P356D8GH
ATC code C07AB04
NIST Chemistry Reference Acebutolol(37517-30-9)
EPA Substance Registry System Butanamide, N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]- (37517-30-9)

Pharmacokinetic data

Protein binding 26%
Excreted unchanged in urine 55%
Volume of distribution 1.2(L/kg)
Biological half-life 3-4 (8-13 for active metabolite) / Increased (32 for active metabolite)

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H362
Precautionary statements  P201-P260-P263-P264-P270-P308+P313
Toxicity TDLo orl-wmn: 152 mg/kg:CVS,BPR JTCTDW 20,69,83
NFPA 704
0
3 0

Acebutolol price More Price(7)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
AK Scientific E887 Acebutolol 37517-30-9 1g $171 2021-12-16 Buy
AK Scientific E887 Acebutolol 37517-30-9 5g $411 2021-12-16 Buy
American Custom Chemicals Corporation API0000343 ACEBUTOLOL 95.00% 37517-30-9 1G $516 2021-12-16 Buy
American Custom Chemicals Corporation API0000343 ACEBUTOLOL 95.00% 37517-30-9 5G $866.87 2021-12-16 Buy
Crysdot CD12077597 N-(3-Acetyl-4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)butyramide 97% 37517-30-9 10g $250 2021-12-16 Buy
Product number Packaging Price Buy
E887 1g $171 Buy
E887 5g $411 Buy
API0000343 1G $516 Buy
API0000343 5G $866.87 Buy
CD12077597 10g $250 Buy

Acebutolol Chemical Properties,Uses,Production

Chemical Properties

Crystalline Solid

Originator

Sectral ,May and Baker ,UK ,1975

Uses

Acebutol is 3′-acetyl-4′-[2-hydroxy-3-(iso-propylamino)propoxy] butyranilide (12.1.6) [9,10].Acebutol is a selective β1-adrenoblocker. It possesses antianginal, antihypotensive, and antiarrhythmic action. It is used for arterial hypertension, preventing attacks of angina, and cardiac rhythm disturbances.

Uses

Cardioselective β-adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic (class II).

Uses

Cardioselective ?adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic (class II)

Definition

ChEBI: An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Manufacturing Process

Crude 5'-butyramido-2'-(2,3-epoxypropoxy)acetophenone (16 g), isopropylamine (20 g) and ethanol (100 ml) were heated together under reflux for 4 hours. The reaction mixture was concentrated under reduced pressure and the residual oil was dissolved in N hydrochloric acid. The acid solution was extracted with ethyl acetate, the ethyl acetate layers being discarded. The acidic solution was brought to pH 11 with 2 N aqueous sodium hydroxide solution and then extracted with chloroform. The dried chloroform extracts were concentrated under reduced pressure to give an oil which was crystallized from a mixture of ethanol and diethyl ether to give 5'-butyramido- 2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone (3 g), MP 119-123°C.
Crude 5'-butyramido-2'-(2,3-epoxypropoxy)acetophenone used as starting material was prepared as follows: p-butyramidophenol (58 g; prepared according to Fierz-David and Kuster, Helv. Chim. Acta 1939,2282), acetyl chloride (25.4 g) and benzene (500 ml) were heated together under reflux until a solution formed (12 hours). This solution was cooled and treated with water. The benzene layer was separated and the aqueous layer was again extracted with benzene.
The combined benzene extracts were dried and evaporated to dryness under reduced pressure to give p-butyramidophenyl acetate (38 g) as an off-white solid, MP 102-103°C. A mixture of p-butyramidophenyl acetate (38 g), aluminum chloride (80 g) and 1,1,2,2-tetrachloroethane (250 ml) was heated at 140°C for 3 hours. The reaction mixture was cooled and treated with iced water. The tetrachloroethane layer was separated and the aqueous layer was extracted with chloroform. The combined organic layers were extracted with 2 N aqueous sodium hydroxide and the alkaline solution was acidified to pH 5 with concentrated hydrochloric acid. The acidified solution was extracted with chloroform and the chloroform extract was dried and concentrated under reduced pressure to give 5'-butyramido-2'-hydroxyacetophenone (15.6 g), MP 114-117°C. A solution of 5'-butyramido-2'-hydroxyacetophenone (15.6 g) in ethanol (100 ml) was added to an ethanolic solution of sodium ethoxide which was prepared from sodium (1.62 g) and ethanol (100 ml). The resulting solution was evaporated to dryness under reduced pressure and dimethylformamide (100 ml) was added to the solid residue. Approximately 10 ml of dimethylformamide was removed by distillation under reduced pressure. Epichlorohydrin (25 ml) was added and the solution was heated at 100°C for 4 hours. The solution was concentrated under reduced pressure to give a residual oil which was treated with water to give a solid. The solid was dissolved in ethanol and the resulting solution was treated with charcoal, filtered and concentrated under reduced pressure to give crude 5'-butyramido- 2'-(2,3-epoxypropoxy)acetophenone (16 g), MP 110-116°C.
The crude compound may be purified by recrystallization from ethyl acetate, after treatment with decolorizing charcoal, to give pure 5'-butyramido-2'-(2,3- epoxypropoxy)acetophenone, MP 136-138°C.

brand name

Sectral (Dr. Reddy’s).

Therapeutic Function

beta-Adrenergic blocker

General Description

Acebutolol is one of the very few β-blockers whosemetabolite plays a significant role in its pharmacological actions.This drug is absorbed well from the gastrointestinaltract, but it undergoes extensive first-pass metabolic conversionto diacetolol by hydrolytic conversion of the amidegroup to the amine, followed by acetylation of the amine. After oral administration, plasma levels of diacetololare higher than those of acebutolol. Diacetolol is also aselective β1-blocker with partial agonistic activity; it has littlemembrane-stabilizing activity. It has a longer half-life (8–12hours) than the parent drug and is excreted by the kidneys.

Clinical Use

Acebutolol (Sectral) is a cardioselective 1-adrenoceptor blocking agent that also has some minor membrane stabilizing effects on the action potential. Acebutolol is effective in the management of the patient with essential hypertension, angina pectoris, and ventricular arrhythmias. Antiarrhythmic effects are observed with the patient both at rest and taking exercise.

Side effects

Adverse effects include bradycardia, gastrointestinal upset, dizziness, and headache.

Safety Profile

Moderately toxic by intravenousroute. Human systemic effects by ingestion: developmentalabnormalities of the cardiovascular and respiratory systems;effects on newborn in biochemical and metabolicabnormalities and reduced growth statistics. A humanter

Drug interactions

Potentially hazardous interactions with other drugs
Anaesthetics: enhanced hypotensive effect.
Analgesics: NSAIDs antagonise hypotensive effect.
Anti-arrhythmics: increased risk of myocardial depression and bradycardia; increased risk of bradycardia, myocardial depression and AV block with amiodarone; increased risk of myocardial depression and bradycardia with flecainide.
Antidepressants: enhanced hypotensive effect with MAOIs.
Antihypertensives: enhanced hypotensive effect; increased risk of withdrawal hypertension with clonidine; increased risk of first dose hypotensive effect with post-synaptic alpha-blockers such as prazosin.
Antimalarials: increased risk of bradycardia with mefloquine.
Antipsychotics enhanced hypotensive effect with phenothiazines.
Calcium-channel blockers: increased risk of bradycardia and AV block with diltiazem; hypotension and heart failure possible with nifedipine and nisoldipine; asystole, severe hypotension and heart failure with verapamil.
Cytotoxics: possible increased risk of bradycardia with crizotinib.
Diuretics: enhanced hypotensive effect.
Fingolimod: possibly increased risk of bradycardia.
Moxisylyte: possible severe postural hypotension.
Sympathomimetics: severe hypertension with adrenaline and noradrenaline and possibly with dobutamine.

Metabolism

About half of an orally administered dose of acebutolol (Sectral) is absorbed. Approximately 25% of the drug is bound to plasma proteins, and its plasma halflife is about 4 hours.Metabolism of acebutolol produces a metabolite with -blocking activity whose half-life is 10 hours.

Precautions

Acebutolol should not be administered in cardiogenic shock, uncontrolled heart failure, or severe bradycardia or to patients with known hypersensitivity to the drug.

Global( 65)Suppliers
Supplier Tel Email Country ProdList Advantage
career henan chemical co
+86-0371-86658258 +8613203830695 factory@coreychem.com China 29811 58
AFINE CHEMICALS LIMITED
+86-0571-85134551 sales@afinechem.com China 15352 58
sgtlifesciences pvt ltd
+8617013299288 dj@sgtlifesciences.com China 12373 58
Amadis Chemical Company Limited
571-89925085 sales@amadischem.com China 131957 58
Mainchem Co., Ltd. +86-0592-6210733 sale@mainchem.com China 32343 55
Chemwill Asia Co.,Ltd. 86-21-51086038 chemwill_asia@126.com CHINA 23912 58
LGM Pharma 1-(800)-881-8210 inquiries@lgmpharma.com United States 2123 70
Syntechem Co.,Ltd info@syntechem.com China 12984 57
China Langchem Inc. 0086-21-58956006 China 7811 57
Shanghai HuanChuan Industry Co.,Ltd. 021-61478794 sales@hcshhai.com China 9793 50

Related articles

  • Uses and Side effects of Acebutolol
  • Acebutolol is used to treat high blood pressure. Acebutolol also is used to treat an irregular heartbeat. Acebutolol is in a c....
  • Nov 8,2019

View Lastest Price from Acebutolol manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
	Acebutolol pictures 2020-01-09 Acebutolol
37517-30-9
US $1.00 / ASSAYS 1ASSAYS 85.0-99.8% 20tons Career Henan Chemical Co
  • 	Acebutolol pictures
  • Acebutolol
    37517-30-9
  • US $1.00 / ASSAYS
  • 85.0-99.8%
  • Career Henan Chemical Co
(.+/-.)-3'-Acetyl-4'-[2-hydroxy-3-(1-methylethylamino)propoxy]butyranilide (.+/-.)-3'-Acetyl-4'-[2-hydroxy-3-(isopropylamino)propoxy]butyranilide (.+/-.)-N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)butanamide 1-(2-Acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane 3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide 5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone Butanamide, N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]-, (.+/-.)- dl-Acebutolol N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide Prent Sectral ACEBUTOLOL n-[3-acetyl-4-(2-hydroxy-3-propan-2-ylamino-propoxy)-phenyl]butanamide Acebutolo HCl Acebutololum AcebutololDiscontinued. See: A123800 Acetobutolol N-(3-acetyl-4-(2-hydroxy-3-(isopropylaMino)propoxy)phenyl)butyraMide Acebutolol USP/EP/BP Acebutolol D7Q: What is Acebutolol D7 Q: What is the CAS Number of Acebutolol D7 Q: What is the storage condition of Acebutolol D7 37517-30-9 Intermediates & Fine Chemicals Pharmaceuticals Adrenoceptor